Standard BioTools price target lowered to $2.50 from $2.75 at TD Cowen
The Fly

Standard BioTools price target lowered to $2.50 from $2.75 at TD Cowen

TD Cowen lowered the firm’s price target on Standard BioTools (LAB) to $2.50 from $2.75 and keeps a Buy rating on the shares. The firm said they reported a 9% sales beat with margins ahead and cost controls solid, though sales upside was largely timing-related.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App